- Home
- STRO vs AUDC Comparison
STRO vs AUDC Comparison
Compare STRO & AUDC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | STRO | AUDC |
|---|---|---|
| Founded | 2003 | 1992 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 85.0M | 267.0M |
| IPO Year | 2018 | 1999 |
Fundamental Metrics
Financial Performance| Metric | STRO | AUDC |
|---|---|---|
| Price | $11.75 | $9.08 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 3 |
| Target Price | ★ $18.29 | $11.67 |
| AVG Volume (30 Days) | ★ 101.4K | 81.4K |
| Earning Date | 11-06-2025 | 02-03-2026 |
| Dividend Yield | N/A | ★ 4.42% |
| EPS Growth | N/A | ★ 15.76 |
| EPS | N/A | ★ 0.46 |
| Revenue | $105,646,000.00 | ★ $244,553,000.00 |
| Revenue This Year | $63.08 | $2.98 |
| Revenue Next Year | N/A | $3.40 |
| P/E Ratio | ★ N/A | $19.49 |
| Revenue Growth | N/A | ★ 0.15 |
| 52 Week Low | $5.23 | $8.01 |
| 52 Week High | $21.50 | $12.72 |
Technical Indicators
Market Signals| Indicator | STRO | AUDC |
|---|---|---|
| Relative Strength Index (RSI) | 75.24 | 53.84 |
| Support Level | $10.15 | $8.67 |
| Resistance Level | $12.18 | $8.96 |
| Average True Range (ATR) | 0.93 | 0.18 |
| MACD | -0.19 | 0.02 |
| Stochastic Oscillator | 85.66 | 70.37 |
Price Performance
Historical ComparisonAbout STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.